Kemnay Advisory Services’s Rapport Therapeutics RAPP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.8K Buy
+351
New +$15.2K ﹤0.01% 707

Other funds holding RAPP

Kemnay Advisory Services's RAPP Position: Q3 2026 in Review

Kemnay Advisory Services opened a new position in Rapport Therapeutics (RAPP) in Q3 2026: 351 shares worth $11.8K. The stake represents ﹤0.01% of the portfolio and ranks #707 among its holdings.

169 funds tracked by Wall St. Rank hold RAPP as of Q3 2026.

  • Kemnay Advisory Services held 351 shares of Rapport Therapeutics worth $11.8K as of Q3 2026.
  • Rapport Therapeutics was a new Kemnay Advisory Services position in Q3 2026.
  • Rapport Therapeutics made up ﹤0.01% of Kemnay Advisory Services's portfolio in Q3 2026, its #707 holding.
  • 169 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q3 2026.

Based on Kemnay Advisory Services's 13F filing for Q3 2026, filed 16 Nov 2026.